Our news

  • Cochrane does not make clinical recommendations, instead it provides unbiased and high-quality health evidence so that health decisions, policies, and clinical guidelines can be informed by the best available evidence. ‘Cochrane Evidence in Practice’ series collects stories about clinical professionals using Cochrane evidence - the everyday...
    November 21 2019
  • New Cochrane Library Special Collection20 November 2019 is the Global Initiative for Chronic Obstructive Pulmonary Disease’s World COPD day. Chronic obstructive pulmonary disease (COPD) is a chronic lung disease. The main symptoms are shortness of breath, cough, and sputum production. COPD is caused by breathing in noxious particles or gases...
    November 20 2019
  • In this blog for men with chronic prostatitis thinking of starting a course of drug treatment, Robert Walton, a Senior Fellow in General Practice, reviews new Cochrane evidence on what medicines have to offer in terms of reduction in symptoms. Worried by that pain in the pelvis – coming and going over the last few months? It’s...
    November 15 2019
  • We have updated our guide to blogging for Evidently Cochrane. This is the guidance we would like our bloggers to follow when preparing their blogs. Read the blogging guide here.Evidently Cochrane is our blog site. It aims to make Cochrane evidence really accessible, and to encourage discussion about it, through blogs which usually feature new...
    November 7 2019
  • In this blog for people with brain arterio-venous malformations (AVMs) and their relatives, Jason Yuen, Neurosurgical Registrar in South West England, looks at the latest Cochrane Review on “Interventions for treating brain arteriovenous malformations in adults” and explores the implications of the review and its limitations.
    November 6 2019
  • Rebecca Selby, a mum of four, shares how a Cochrane Review impacted her family.When I unexpectedly went into premature labour with our second son at a little under 32 weeks' gestation, I was given steroid injections to give his lungs the best possible chance in the outside world. George spent almost a month in intensive care when he was born,...
    November 6 2019
  • After ten years at the helm of the Cochrane Library, Dr David Tovey recently stepped down as Editor-in-Chief. In this podcast, David joins Ray to reflect on Cochrane’s past, present and future and share some of the challenges and rewards of leading one of the world’s largest and most trusted health research networks.Listen to Recommended Dose...
    November 6 2019
  • Watch the webinar on how to improve Cochrane dissemination products and share Cochrane evidence more effectivelyKnowledge Translation (KT) in Cochrane is delighted to announce the launch of its Dissemination Checklist - a new resource that can improve the quality, consistency and translatability of dissemination products that present findings of a...
    November 6 2019
  • In a blog for health professionals, Kinseng Tong looks at the latest Cochrane evidence on intravenous fluid resuscitation.
    November 1 2019
  • Fluoxetine is a medicine used for the treatment of depression, which reduces appetite as a side effect. Therefore, it is suspected that fluoxetine could be used as a treatment for overweight or obese people. In this group of people administration of fluoxetine means an off-label treatment which means it is not licensed for treating obesity.The...
    October 29 2019

Pages

Subscribe to Our news